Literature DB >> 10887726

Sedation for delirium and other symptoms in terminally ill patients in Edmonton.

R L Fainsinger1, D De Moissac, I Mancini, D Oneschuk.   

Abstract

The use of sedation and the management of delirium and other difficult symptoms in terminally ill patients in Edmonton has been reported previously. The focus of this study was to assess the prevalence in the Edmonton region of difficult symptoms requiring sedation at the end of life. Data were collected for 50 consecutive patients at each of (a) the tertiary palliative care unit, (b) the consulting palliative care program at the Royal Alexandra Hospital (acute care), and (c) three hospice inpatient units in the city. Patients on the tertiary palliative care unit were significantly younger. Assessments confirmed the more problematic physical and psychosocial issues of patients in the tertiary palliative care unit. These patients had more difficult pain syndromes and required significantly higher doses of daily opioids. Approximately 80% of patients in all three settings developed delirium prior to death. Pharmacological management of this problem was needed by 40% in the acute care setting, and by 80% in the tertiary palliative care unit. The patients sedated varied from 4% in the hospice setting to 10% in the tertiary palliative care unit. Of the 150 patients, nine were sedated for delirium, one for dyspnea. The prevalence of delirium and other symptoms requiring sedation in our area is relatively low compared to others reported in the literature. Demographic variability between the three Edmonton settings highlights the need for caution in comparing results of different palliative care groups. It is possible that some variability in the use of sedation internationally is due to cultural differences. The infrequent deliberate use of sedation in Edmonton suggests that improved management has resulted in fewer distressing symptoms at the end of life. This is of benefit to patients and to family members who are with them during this time.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10887726

Source DB:  PubMed          Journal:  J Palliat Care        ISSN: 0825-8597            Impact factor:   2.250


  12 in total

Review 1.  Practical guide to palliative sedation.

Authors:  John D Cowan; Teresa W Palmer
Journal:  Curr Oncol Rep       Date:  2002-05       Impact factor: 5.075

Review 2.  Delirium: an important (but often unrecognized) clinical syndrome.

Authors:  Terry Rabinowitz
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 5.285

Review 3.  [Sedation in palliative medicine: Guidelines for the use of sedation in palliative care : European Association for Palliative Care (EAPC)].

Authors:  B Alt-Epping; T Sitte; F Nauck; L Radbruch
Journal:  Schmerz       Date:  2010-08       Impact factor: 1.107

4.  Efficacy and safety of deep, continuous palliative sedation at home: a retrospective, single-institution study.

Authors:  Giampiero Porzio; Federica Aielli; Lucilla Verna; Giovanna Micolucci; Paolo Aloisi; Corrado Ficorella
Journal:  Support Care Cancer       Date:  2009-04-03       Impact factor: 3.603

5.  Palliative sedation-still a complex clinical issue!

Authors:  R L Fainsinger
Journal:  Curr Oncol       Date:  2014-04       Impact factor: 3.677

Review 6.  Sedation in clinical oncology.

Authors:  Manuel González Barón; César Gómez Raposo; Alvaro Pinto Marín
Journal:  Clin Transl Oncol       Date:  2005-08       Impact factor: 3.405

7.  Impact of delirium and recall on the level of distress in patients with advanced cancer and their family caregivers.

Authors:  Eduardo Bruera; Shirley H Bush; Jie Willey; Timotheos Paraskevopoulos; Zhijun Li; J Lynn Palmer; Marlene Z Cohen; Debra Sivesind; Ahmed Elsayem
Journal:  Cancer       Date:  2009-05-01       Impact factor: 6.860

8.  Attitudes towards terminal sedation: an empirical survey among experts in the field of medical ethics.

Authors:  Alfred Simon; Magdalene Kar; José Hinz; Dietmar Beck
Journal:  BMC Palliat Care       Date:  2007-04-16       Impact factor: 3.234

9.  Use of Opioids and Sedatives at End-of-Life.

Authors:  Shin Wei Sim; Shirlynn Ho; Radha Krishna Lalit Kumar
Journal:  Indian J Palliat Care       Date:  2014-05

10.  Pharmaceutical studies on and clinical application of olanzapine suppositories prepared as a hospital preparation.

Authors:  Kazuaki Matsumoto; Satoru Kimura; Kenichi Takahashi; Yuta Yokoyama; Masayuki Miyazawa; Satoko Kushibiki; Morio Katamachi; Junko Kizu
Journal:  J Pharm Health Care Sci       Date:  2016-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.